X-71141265-GCAGCAA-GCAGCAACAGCAA

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP3BP6BS1BS2

The NM_005120.3(MED12):​c.6315_6320dupACAGCA​(p.Gln2106_Gln2107dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000101 in 108,870 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. Q2107Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00010 ( 0 hom., 2 hem., cov: 23)
Exomes 𝑓: 0.000018 ( 0 hom. 4 hem. )
Failed GnomAD Quality Control

Consequence

MED12
NM_005120.3 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 2.20

Publications

1 publications found
Variant links:
Genes affected
MED12 (HGNC:11957): (mediator complex subunit 12) The initiation of transcription is controlled in part by a large protein assembly known as the preinitiation complex. A component of this preinitiation complex is a 1.2 MDa protein aggregate called Mediator. This Mediator component binds with a CDK8 subcomplex which contains the protein encoded by this gene, mediator complex subunit 12 (MED12), along with MED13, CDK8 kinase, and cyclin C. The CDK8 subcomplex modulates Mediator-polymerase II interactions and thereby regulates transcription initiation and reinitation rates. The MED12 protein is essential for activating CDK8 kinase. Defects in this gene cause X-linked Opitz-Kaveggia syndrome, also known as FG syndrome, and Lujan-Fryns syndrome. [provided by RefSeq, Aug 2009]
MED12 Gene-Disease associations (from GenCC):
  • FG syndrome 1
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • MED12-related intellectual disability syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked intellectual disability with marfanoid habitus
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • blepharophimosis - intellectual disability syndrome, MKB type
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
  • cholestasis-pigmentary retinopathy-cleft palate syndrome
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_005120.3
BP6
Variant X-71141265-G-GCAGCAA is Benign according to our data. Variant chrX-71141265-G-GCAGCAA is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 445536.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.000101 (11/108870) while in subpopulation AFR AF = 0.000268 (8/29801). AF 95% confidence interval is 0.000133. There are 0 homozygotes in GnomAd4. There are 2 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MED12NM_005120.3 linkc.6315_6320dupACAGCA p.Gln2106_Gln2107dup disruptive_inframe_insertion Exon 43 of 45 ENST00000374080.8 NP_005111.2 Q93074-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MED12ENST00000374080.8 linkc.6315_6320dupACAGCA p.Gln2106_Gln2107dup disruptive_inframe_insertion Exon 43 of 45 1 NM_005120.3 ENSP00000363193.3 Q93074-1

Frequencies

GnomAD3 genomes
AF:
0.000101
AC:
11
AN:
108870
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000268
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000984
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000383
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000440
AC:
5
AN:
113583
AF XY:
0.0000246
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000205
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000233
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0000181
AC:
19
AN:
1050407
Hom.:
0
Cov.:
32
AF XY:
0.0000117
AC XY:
4
AN XY:
341563
show subpopulations
African (AFR)
AF:
0.000121
AC:
3
AN:
24850
American (AMR)
AF:
0.000179
AC:
5
AN:
27910
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
18616
East Asian (EAS)
AF:
0.00
AC:
0
AN:
27122
South Asian (SAS)
AF:
0.00
AC:
0
AN:
49773
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
37626
Middle Eastern (MID)
AF:
0.000247
AC:
1
AN:
4041
European-Non Finnish (NFE)
AF:
0.00000980
AC:
8
AN:
816221
Other (OTH)
AF:
0.0000452
AC:
2
AN:
44248
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000101
AC:
11
AN:
108870
Hom.:
0
Cov.:
23
AF XY:
0.0000633
AC XY:
2
AN XY:
31608
show subpopulations
African (AFR)
AF:
0.000268
AC:
8
AN:
29801
American (AMR)
AF:
0.0000984
AC:
1
AN:
10159
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2614
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3432
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2535
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5706
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
226
European-Non Finnish (NFE)
AF:
0.0000383
AC:
2
AN:
52274
Other (OTH)
AF:
0.00
AC:
0
AN:
1452
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

FG syndrome Uncertain:1
Dec 31, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant, c.6315_6320dup, results in the insertion of 2 amino acid(s) of the MED12 protein (p.Gln2114_Gln2115dup), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with MED12-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Familial thoracic aortic aneurysm and aortic dissection Benign:1
Feb 13, 2025
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
Jun 15, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.2
Mutation Taster
=79/21
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs764789036; hg19: chrX-70361115; API